In moderately severe CAP stable after 3 d of β-lactam, stopping therapy was noninferior to 5 additional d.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 34339227.
- Also identified by DOI 10.7326/ACPJ202108170-087.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dinh A, Ropers J, Duran C, et al. <b>Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.</b> Lancet. 2021;397:1195-1203. 33773631.
Medical subject headings
- Community-Acquired Infections
- Pneumonia, Bacterial